2.Sentinel surveillance for viral hepatitis C in China, 2016-2017.
G W DING ; S D YE ; F X HEI ; Q L LIAN ; X D PEI ; J Y BAI ; D ZHOU ; Q YANG ; S HUI ; W WANG ; A X TU ; L PANG
Chinese Journal of Epidemiology 2019;40(1):41-45
Objective: To understand the prevalence of hepatitis C virus (HCV) infection in 5 populations in China during 2016-2017 and provide evidence for the estimation of prevalence trend of hepatitis C and evaluation on the prevention and control effect. Methods: A total of 87 national sentinel surveillance sites for hepatitis C were set up in 31 provinces (autonomous regions and municipalities) of China to obtain the information about HCV infection prevalence in 5 populations, including volunteer blood donors, people receiving physical examination, patients receiving invasive diagnosis and treatment, patients receiving hemodialysis, and clients visiting family planning outpatient clinics. From April to June, 2016 and 2017, cross-sectional surveys were repeatedly conducted in the 5 populations and blood samples were collected from them for HCV antibody detection. Results: In 2016, 86 sentinel sites completed the surveillance (one sentinel site was not investigated), and 115 841 persons were surveyed. The overall HCV positive rate was 0.38% (442/115 841, 95%CI: 0.23%-0.53%). In 2017, all the 87 sentinel sites completed the surveillance, and 120 486 persons were surveyed. The overall HCV positive rate was 0.37% (449/120 486, 95%CI: 0.23%-0.52%). In 2016 and 2017, the anti-HCV positive rates were 4.46% (223/5 005, 95%CI: 2.18%-6.73%) and 4.39% (216/4 919, 95%CI: 2.29%-6.50%) respectively in hemodialysis patients, 0.85% (44/5 200, 95%CI: 0.27%-1.42%) and 0.70% (36/5 150, 95%CI: 0.15%-1.24%) respectively in patients receiving invasive diagnosis and treatment and remained to be ≤0.25% in volunteer blood donors, people receiving physical examination and clients visiting family planning outpatient clinics. Results for the comparison of the anti-HCV positive rates in the 5 populations indicated that the differences were significant (F=23.091, P<0.001 in 2016 and F=20.181, P<0.001 in 2017). Conclusions: Data from the sentinel surveillance of HCV infection on prevalence in China showed that the anti-HCV positive rates varied in the 5 populations during 2016-2017. The anti-HCV positive rate appeared the highest in the hemodialysis patients, followed by that in the patients receiving invasive diagnosis and treatment, and the prevalence of HCV infection in other 3 populations were at low levels.
China/epidemiology*
;
Cross-Sectional Studies
;
Hepacivirus
;
Hepatitis C/epidemiology*
;
Hepatitis C Antibodies
;
Humans
;
Prevalence
;
Sentinel Surveillance
3.Fujian Tulou Family Cohort Study: study design and characteristics of participants and pedigrees in baseline investigation.
H HUANG ; Y YE ; C L HUANG ; W J GAO ; M Y WANG ; W Y LI ; R ZHOU ; C Q YU ; J LYU ; X L WU ; X M HUANG ; W H CAO ; Y S YAN ; T WU ; L M LI
Chinese Journal of Epidemiology 2018;39(10):1402-1407
Objective: To describe the study design, the characteristics of participants as well as the pedigrees included in the baseline survey of Fujian Tulou Family Cohort Study. Methods: Fujian Tulou Family Cohort Study was a prospective open cohort study with a biological sample bank. A baseline survey was conducted in Tulou areas of Nanjing county in Fujian province from 2015 to 2018, including questionnaire survey, physical and biochemical indicators examinations, and blood sample collection in adults aged ≥18 years. In addition, family relationship of the participants was also recorded. The pedigree information of the juveniles under 18 years old were also collected. Results: The baseline survey included 2 727 individuals in two clans, of whom 2 373 (87.0%) were adults, and 2 126 participants completed questionnaires, physical examinations and biochemical tests. The average age of the 2 126 participants was (57.9±13.3) years, with 39.4% being males. The current smoking rates in male and female participants were 41.2% and 2.1%, respectively. The corresponding rates of current alcohol consumption were 19.0% and 2.6%. For common chronic diseases, the prevalence rates were 51.3% for hypertension, 9.7% for diabetes and 26.7% for hyperlipemia according to the self-reported disease diagnoses, health examination results and biochemical examination results in class Ⅱ or Ⅲ hospitals. Based on the family relationship information and genealogical data, 710 pedigrees were finally identified, consisting of 5 087 family members. The numbers of five, four, three, and two generations pedigrees were 3, 88, 238 and 381, respectively. The pairs of the first to the fifth degree relatives were 12 039, 2 662, 1 511, 202 and 31, respectively. Conclusion: The establishment of Fujian Tulou Family Cohort provides valuable resources for exploring the genetic risk factors, environmental risk factors and gene-environment interactions contributing to the risk of common chronic diseases.
Adolescent
;
Adult
;
Aged
;
China/epidemiology*
;
Chronic Disease/ethnology*
;
Cohort Studies
;
Diabetes Mellitus/ethnology*
;
Family Health
;
Female
;
Gene-Environment Interaction
;
Genetic Predisposition to Disease/ethnology*
;
Humans
;
Hyperlipidemias/ethnology*
;
Hypertension/ethnology*
;
Male
;
Middle Aged
;
Pedigree
;
Prospective Studies
;
Risk Factors
;
Surveys and Questionnaires
4.Seasonal distribution of patient hospitalization due to asthma exacerbation in 7 geographic areas in China.
J T LIN ; B XING ; H P TANG ; L YANG ; Y D YUAN ; Y H GU ; P CHEN ; X J LIU ; J ZHANG ; H G LIU ; C Z WANG ; W ZHOU ; D J SUN ; Y Q CHEN ; Z C CHEN ; M HUANG ; Q C LIN ; C P HU ; X H YANG ; J M HUO ; X W YE ; X ZHOU ; P JIANG ; W ZHANG ; Y J HUANG ; L M DAI ; R Y LIU ; S X CAI ; J Y XU ; J Y ZHOU
Chinese Journal of Epidemiology 2018;39(11):1477-1481
Objective: To understand the seasonal distribution of patient hospitalization due to asthma exacerbation in 7 geographic areas in China. Methods: This was a retrospective study which involved patients hospitalized for asthma exacerbation in 29 hospitals throughout 7 geographic areas in the mainland of China (northeast, north, central, east, south, northwest and southwest). The numbers of asthmatic patients and total inpatients of the respiratory department of each hospital were recorded. The monthly ratio of asthmatic patients to the total inpatients in every area was calculated and compared. Results: During the study period, 6 480 patients were admitted for asthma exacerbation, accounting for 3.14% of all the 206 135 patients admitted to the respiratory departments in the 29 hospitals. The ratio of asthmatic patients to total inpatients in the northeast area (5.61%) was highest, and the ratio in east area was lowest (1.97%). Statistical analysis showed that the difference among different areas was significant (P<0.000 1). In most areas, both the number and proportion of hospitalized asthmatic patients peaked in spring (February-April) and autumn (September-October). In the northeast area, east area and south area, the peaks in spring were more obvious, while in the north area and southwest area, the peaks in autumn were more obvious. In the northwest area the peaks occurred in winter (December-January) and summer (June-August), respectively. The differences in hospitalization due to asthma among different months were significant in the northeast, north, and southwest areas (P<0.005). Conclusion: The number of patients hospitalized for asthma exacerbation fluctuated with season in different areas in China. In most areas, more asthmatic patients were admitted to hospitals in spring and autumn.
Asthma
;
China/epidemiology*
;
Hospitalization/statistics & numerical data*
;
Humans
;
Retrospective Studies
;
Seasons